Background:
- Up to 30% of children and adolescents with Crohn's disease have decreased bone strength,
or decrease bone density, called osteopenia.
- Bisphosphonates are a group of drugs that have been well studied and found to be
effective in the treatment of osteopenia in menopausal women.
- Zoledronate is a very potent third generation bisphosphonate, that is safe and easy to
administer, and has been found effective in the treatment of menopausal women with
osteopenia.
Hypothesis: The investigators hypothesize that zoledronate can improve bone density in
children and adolescents with Crohn's disease with osteopenia.
Phase:
Phase 3
Details
Lead Sponsor:
McGill University Health Center McGill University Health Centre/Research Institute of the McGill University Health Centre